Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 1.14% vs 3.36% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -29.86% vs 175.59% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -29.47% vs 192.93% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 69.23% vs -61.76% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Mayinglong Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 1.14% vs 3.36% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.33% vs 20.91% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -29.86% vs 175.59% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 22.34% vs 15.55% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -29.47% vs 192.93% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 14.79% vs 42.01% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 69.23% vs -61.76% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -26.67% vs -28.57% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






